Free Trial

ASR Vermogensbeheer N.V. Decreases Stock Holdings in Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background

Key Points

  • ASR Vermogensbeheer N.V. has reduced its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 9.9%, now owning 20,202 shares valued at approximately $10.36 million.
  • Synopsys' stock price declined by 3.6%, and the company's market cap is currently $87.51 billion with a price-to-earnings ratio of 36.98.
  • Analyst ratings for Synopsys have been mixed, with eleven analysts giving a Buy rating and others setting revised price targets between $425.00 and $600.00.
  • Interested in Synopsys? Here are five stocks we like better.

ASR Vermogensbeheer N.V. reduced its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 9.9% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 20,202 shares of the semiconductor company's stock after selling 2,217 shares during the period. ASR Vermogensbeheer N.V.'s holdings in Synopsys were worth $10,357,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the business. Independence Bank of Kentucky grew its position in Synopsys by 120.0% in the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company's stock worth $28,000 after acquiring an additional 30 shares in the last quarter. Cornerstone Planning Group LLC raised its position in Synopsys by 275.0% during the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock valued at $25,000 after purchasing an additional 44 shares during the period. Saudi Central Bank bought a new stake in shares of Synopsys in the 1st quarter valued at approximately $26,000. Clal Insurance Enterprises Holdings Ltd boosted its holdings in shares of Synopsys by 441.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 53 shares during the period. Finally, WPG Advisers LLC bought a new position in shares of Synopsys during the 1st quarter valued at approximately $34,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Stock Down 3.6%

NASDAQ:SNPS opened at $471.14 on Friday. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The company has a 50-day moving average of $561.80 and a 200 day moving average of $509.25. The firm has a market cap of $87.51 billion, a PE ratio of 36.98, a price-to-earnings-growth ratio of 5.39 and a beta of 1.10.

Analyst Ratings Changes

SNPS has been the subject of a number of analyst reports. JPMorgan Chase & Co. lowered their price target on Synopsys from $685.00 to $600.00 and set an "overweight" rating for the company in a research report on Wednesday, September 10th. Wall Street Zen lowered shares of Synopsys from a "hold" rating to a "sell" rating in a report on Saturday, September 13th. BNP Paribas initiated coverage on shares of Synopsys in a research note on Thursday. They set an "underperform" rating and a $425.00 price target for the company. Mizuho reduced their price objective on shares of Synopsys from $700.00 to $600.00 and set an "outperform" rating on the stock in a research report on Thursday, September 11th. Finally, Rosenblatt Securities reissued a "neutral" rating and issued a $605.00 price objective (down previously from $650.00) on shares of Synopsys in a research note on Wednesday, September 10th. Eleven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and four have given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $575.31.

Read Our Latest Stock Analysis on Synopsys

Insider Buying and Selling at Synopsys

In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of the company's stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the completion of the sale, the chief accounting officer owned 20,520 shares in the company, valued at $10,278,468. This represents a 32.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Shelagh Glaser sold 3,655 shares of the stock in a transaction on Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the sale, the chief financial officer directly owned 15,317 shares in the company, valued at $9,339,847.09. This trade represents a 19.27% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 30,894 shares of company stock worth $16,760,783 over the last quarter. 0.62% of the stock is currently owned by company insiders.

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.